Steven Fleming, PhD concludes the conversation with Michel De Vos, MD, PhD and Robert Gilchirst, PhD by talking about the promising future IVM has in both fertility preservation and infertility treatment. <hr> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

Steven Fleming, PhD concludes the conversation with Michel De Vos, MD, PhD and Robert Gilchirst, PhD by talking about the promising future IVM has in both fertility preservation and infertility treatment. See acast.com/privacy for privacy and opt-out information.

Steven Fleming, PhD concludes the conversation with Michel De Vos, MD, PhD and Robert Gilchirst, PhD by talking about the promising future IVM has in both fertility preservation and infertility treatment. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for privacy and opt-out information.

Fertility preservation for cancer patients: The possible bright future of in-vitro maturation (IVM) and patient outcomes

Through knowledge-sharing, we aim to encourage continued innovation in the field of assisted reproductive technology, and we are delighted to work with a global network of scientific leaders, embryologists and clinical training experts.We are excited to bring conversations with these experts to you, sharing their scientific insights. Get in touch with any questions or topic suggestions on our social channels. Please note the views expressed by our guests are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent.Thanks for joining us.&nbsp; <hr> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

Science

Natural Sciences

Through knowledge-sharing, we aim to encourage continued innovation in the field of assisted reproductive technology, and we are delighted to work with a global network of scientific leaders, embryologists and clinical training experts. We are excited to bring conversations with these experts to you, sharing their scientific insights. Get in touch with any questions or topic suggestions on our social channels. Please note the views expressed by our guests are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent. Thanks for joining us.  See acast.com/privacy for privacy and opt-out information.

Through knowledge-sharing, we aim to encourage continued innovation in the field of assisted reproductive technology, and we are delighted to work with a global network of scientific leaders, embryologists and clinical training experts.We are excited to bring conversations with these experts to you, sharing their scientific insights. Get in touch with any questions or topic suggestions on our social channels. Please note the views expressed by our guests are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent.Thanks for joining us.&nbsp; See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for privacy and opt-out information.

Share Fertility preservation for cancer patients: The possible bright future of in-vitro maturation (IVM) and patient outcomes

Sign up to save your podcasts

Fertility preservation for cancer patients: The possible bright future of in-vitro maturation (IVM) and patient outcomes

Fertility preservation for cancer patients: The possible bright future of in-vitro maturation (IVM) and patient outcomes